Overview
What is Children's Tumor Foundation?
The Children's Tumor Foundation is a New York-based nonprofit organization that is committed to ending Neurofibromatosis (NF) through extensive research efforts. With a staff of 48 individuals, they invest in research by attracting talented investigators, supporting innovative studies, and fostering collaborative projects to develop treatments and cures for NF. The Foundation has played a significant role in discoveries, including the NF1 and NF2 genes, groundbreaking clinical trials, and the establishment of the first nationwide NF clinic network and patient registry. Annually, they sponsor a scientific conference to bring researchers together and share recent developments related to NF. Additionally, they aim to increase public awareness, support patients and families, and encourage the establishment of NF clinics.
Official website here: www.ctf.org
Is Children's Tumor Foundation legitimate?
Children's Tumor Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Children's Tumor Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $616,398
Professional Fundraising Fees: $100,000
Other Salaries and Wages: $3,653,215
For more financial information, click here
Official website here: www.ctf.org
What is the mission statement of Children's Tumor Foundation?
The Children's Tumor Foundation is committed to ending Neurofibromatosis (NF), a genetic disorder. Their mission encompasses several areas: funding research, increasing public awareness, supporting patients and families, and encouraging the establishment of NF clinics. In the realm of research, the foundation invests in attracting talented researchers, supporting innovative projects, and fostering collaborative efforts to discover treatments and cures for NF. The foundation has been instrumental in key research advancements, such as funding the laboratories that discovered the NF1 and NF2 genes, sponsoring groundbreaking clinical trials, and establishing the first nationwide NF clinic network and patient registry. Annually, they bring researchers together to discuss the latest scientific developments related to NF. Additionally, their programs integrate with and support larger federally funded projects through the Congressionally Directed Medical Research Program (CDMRP) and National Institutes of Health (NIH).
Official website here: www.ctf.org
Who is the CEO of Children's Tumor Foundation?
Annette Bakker Phd is the Board Member of Children's Tumor Foundation.
Official website here: www.ctf.org
What is the revenue of Children's Tumor Foundation?
Who are the executives of Children's Tumor Foundation and what are their salaries?
The average compensation at Children's Tumor Foundation during 2022 was $88,950. There are 48 employees and 1,000 volunteers at Children's Tumor Foundation.
Here are 38 key members and their salaries:
- Annette Bakker (President)
- Michele Przypyszny (Chief Advancement Officer)
- Salvatore La Rosa (Chief Scientific Officer)
- Simon Vukelj (Chief Marketing Officer)
- Barbara Gallagher (Vice President Of Dev.)
- Sarah Bourne (Vp, Finance And Operations)
- Patrice Pancza (Vp, External Relations)
- Anita Gribben (Board Member) [Trustee/Director]
- Carol Kalagher (Board Member) [Trustee/Director]
- Carolyn Setlow (Board Member) [Trustee/Director]
- Daniel Altman (Board Member) [Trustee/Director]
- Daniel Gilbert (Board Member) [Trustee/Director]
- Ed Stern (Board Member) [Trustee/Director]
- Emily Parker (Board Member) [Trustee/Director]
- Frank Haughton (Board Member) [Trustee/Director]
- Gabriel Groisman (Vice Chair) [Trustee/Director]
- George Thuronyi (Board Member) [Trustee/Director]
- John Golfinos (Board Member) [Trustee/Director]
- Kenneth Rudd (Board Member) [Trustee/Director]
- Linda H Martin (Chair Emeritus) [Trustee/Director]
- Liz Rodbell (Board Member) [Trustee/Director]
- Michael Peterson (Board Member (Outgoing)) [Trustee/Director]
- Nate Walker (Board Member (Outgoing)) [Trustee/Director]
- Randall Stanicky (Treasurer) [Trustee/Director]
- Rb Harrison (Board Member) [Trustee/Director]
- Richard Horvitz (Chair Emeritus) [Trustee/Director]
- Richard Soll (Board Member) [Trustee/Director]
- Robert Brainin (Board Member) [Trustee/Director]
- Roger - Ketcha Ngassam (Board Member) [Trustee/Director]
- Sally Gottesman (Board Member) [Trustee/Director]
- Scott Plotkin (Board Member) [Trustee/Director]
- Simone Manso (Board Member) [Trustee/Director]
- Steven Mckenzie (Board Member) [Trustee/Director]
- Stuart Suna (Board Member) [Trustee/Director]
- Suzanne Earle (Board Member (Outgoing)) [Trustee/Director]
- Terri Rawson (Board Member) [Trustee/Director]
- Tracy Galloway (Chair) [Trustee/Director]
- Wade Clapp (Board Member) [Trustee/Director]
Official website here: www.ctf.org
Where can I find the form 990 for Children's Tumor Foundation?
The Children's Tumor Foundation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.ctf.org
Learn more at the official website: www.ctf.org
Mission Statement of Children's Tumor Foundation
The Children's Tumor Foundation is a dedicated organization that strives to put an end to Neurofibromatosis (NF), a condition that affects many individuals. With a clear mission, the Foundation aims to: fund research, increase public awareness, support patients and families, and encourage the establishment of NF clinics.
In simple terms, the Children's Tumor Foundation's mission is to drive research, expand knowledge, and advance care for the NF community. Their ultimate goal is to end NF. The Foundation's investments in research are multifaceted, serving three primary purposes: attracting talented investigators to NF research, supporting innovative research, and fostering collaborative efforts to find treatments and cures for Neurofibromatosis.
Over the years, the Children's Tumor Foundation has been at the forefront of significant advancements in NF research. Some key achievements include funding laboratories that discovered the NF1 and NF2 genes, sponsoring groundbreaking clinical trials, and establishing the first nationwide NF clinic network and NF patient registry. Additionally, the Foundation sponsors an annual scientific conference where researchers gather to discuss the latest scientific developments related to NF. Furthermore, the Foundation's programs are designed to integrate and support larger federally funded projects through the Congressionally Directed Medical Research Program (CDMRP) and the National Institutes of Health (NIH).
Impact
This information is meant to be a general summary of Children's Tumor Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Children's Tumor Foundation is dedicated to ending neurofibromatosis (NF) by funding research, increasing public awareness, supporting patients and families, and encouraging the establishment of NF clinics. Through a range of funding mechanisms, the foundation attracts talented investigators to NF research, supports innovative research, and fosters collaborative efforts to find treatments and cures for neurofibromatosis.
The foundation has played a significant role in key advances in NF research, including funding the laboratories that discovered the NF1 and NF2 genes, supporting groundbreaking clinical trials, and establishing the first nationwide NF clinic network and NF patient registry. Additionally, the foundation sponsors an annual scientific conference that brings researchers together to discuss the latest scientific developments related to NF.
Overall, the Children's Tumor Foundation's impact is in driving research, expanding knowledge, and advancing care for the NF community with a vision to ultimately end NF.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PARTICIPANT REVENUE
Revenue
$1,169,034
Organization Details
Founding Year
1978
Phone
(212) 344-6633
Principal Officer
Annette Bakker Phd
Main Address
697 3RD AVENUE 418, NEW YORK, NY, 10017
Website
www.ctf.org
NTEE Category
Code: H50Z - Medical research
If you are a representative of Children's Tumor Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.